Long-term prognostic value of CFVR and FFR versus perfusion scintigraphy in patients with multivessel disease

Netherlands Heart Journal

Volumn 15, Issue 11, 2007, Pages 369-374

  Chamuleau, S A J ^a   Van Eck Smit, B L F ^a   Meuwissen, M ^a   Koch, K T ^a   Dijkgraaf, M G W ^a   Verberne, H J ^a   Tijssen, J G P ^a   Piek, J J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Angioplasty; Coronary artery disease; Coronary flow velocity reserve; Fractional flow reserve; Myocardial perfusion scintigraphy; Risk stratification

Indexed keywords

DIPYRIDAMOLE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; HEART CATHETERIZATION; HEART HEMODYNAMICS; HEART MUSCLE PERFUSION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PATIENT REFERRAL; PROGNOSIS; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 36749084014     PISSN: 15685888     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03086017     Document Type: Article

References (18)

1. Berman DS, Germano G, Shaw LJ. The role of nuclear cardiology in clinical decision making. Semin Nucl Med 1999;29:280-97.
2. Kern MJ, Lerman A, Bech J-W, De Bruyne B, Eeckhout E, Fearon WF, et al. Physiological Assessment of Coronary Artery Disease in the Cardiac Catheterization Laboratory: A Scientific Statement From the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology. Circulation 2006;114:1321-41.
3. Heller LI, Cates C, Popma J, Deckelbaum LI, Joye JD, Dahlberg ST, et al. Intracoronary Doppler assessment of moderate coronary artery disease: comparison with 201Tl imaging and coronary angiography. FACTS Study Group. Circulation 1997;96:484-90.
4. Pijls NHJ, De Bruyne B, Peels K, van der Voort PH, Bonnier HJ, Bartunek J, et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med 1996;334:1703- 8.
5. Chamuleau SAJ, Meuwissen M, Van Eck-Smit BLF, Koch KT, de Jong A, de Winter RJ, et al. Fractional flow reserve, absolute and relative coronary blood flow velocity reserve in relation to the results of technetium-99m sestamibi single photon emission computed tomography in patients with two-vessel coronary artery disease. J Am Coll Cardiol 2001;37:1316-22.
6. Chamuleau SAJ, Tio RA, De Cock CC, De Muinck ED, Pijls NHJ, van Eck-Smit BLF, et al. Prognostic value of coronary blood flow velocity and myocardial perfusion in intermediate coronary narrowings and multivessel disease. J Am Coll Cardiol 2002;39:852-8.
7. Bech GJW, De Bruyne B, Pijls NHJ, de Muinck ED, Hoorntje JCA, Escaned J, et al. Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial. Circulation 2001;103:2928-34.
8. Van der Zwet PM, Reiber JH. A new approach for the quantification of complex lesion morphology: the gradient field transform; basic principles and validation results. J Am Coll Cardiol 1994;24:216-24.
9. Verberne HJ, Piek JJ, van Liebergen RAM, Koch KT, Schroeder-Tanka JM, van Royen EA. Functional assessment of coronary artery stenosis by Doppler derived absolute and relative coronary blood flow velocity reserve in comparison with Tc-99m MIBI SPECT. Heart 1999;82:509-14.
10. Strauss HW, Miller DD, Wittry MD, Cerqueira MD, Garcia EV, Iskandrian AS, et al. Procedure guideline for myocardial perfusion imaging. J Nucl Med 1998;39:918-23.
11. Gould KL, Kirkeeide RL, Buchi M. Coronary flow reserve as a physiologic measure of stenosis severity. J Am Coll Cardiol 1990;15:459-74.
12. Wijpkema JS, Van der Vleuten PA, Jessurun GA, Tio RA. Longterm safety of intracoronary haemodynamic assessment for deferral of angioplasty in intermediate coronary stenoses: a 5-year follow-up. Acta Cardiol 2005;60:207-11.
13. Mates M, Hrabos V, Hajek P, Rataj O, Vojacek J. Long-term follow-up after deferral of coronary intervention based on myocardial fractional flow reserve measurement. Coron Artery Dis 2005;16:169-74.
14. Berger A, Botman KJ, MacCarthy PA, Wijns W, Bartunek J, Heyndrikx GR, et al. Long-term clinical outcome after fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease. J Am Coll Cardiol 2005;46:438-42.
15. Hachamovitch R, Berman DS. The use of nuclear cardiology in clinical decision making. Semin Nucl Med 2005;35:62-72.
16. Berman DS, Hachamovitch R, Shaw LJ, Friedman JD, Hayes SW, Thomson LE, et al. Roles of nuclear cardiology, cardiac computed tomography, and cardiac magnetic resonance: Noninvasive risk stratification and a conceptual framework for the selection of noninvasive imaging tests in patients with known or suspected coronary artery disease. J Nucl Med 2006;47:1107-18.
17. Chamuleau SAJ, Dijkgraaf MGW, van Eck-Smit BLF, Tijssen JGP, Piek JJ. Cost-effectiveness of intracoronary flow velocity measurements and myocardial perfusion scintigraphy for management of intermediate coronary lesions. Neth Heart J 2005;13:214-23.
18. Fearon WF, Yeung AC, Lee DP, Yock PG, Heidenreich PA. Cost-effectiveness of measuring fractional flow reserve to guide coronary interventions. Am Heart J 2003;145:882-7.